Dear ESPT members,
It is my great honor to welcome you as new president of ESPT. I want to express my thanks to the Board for trusting me in this important task within our Society. I will try my utmost to continue the excellent work that our past president, Prof Gerard Siest, has accomplished in setting up and shaping ESPT. In that aspect, I feel very privileged to work together with the current ESPT board and vice president Vangelis Manolopoulos.
I want to express my thanks, on behalf of the ESPT Board, for the excellent work of the Nominating Committee, Urs Meyer, Magnus Ingelman-Sundberg, Marc Ansari ad Michael Oellerich, for their efforts in interviewing many candidates for the ESPT Executive Board, and for providing valuable advices as to the direction and organization of ESPT. In August, an invitation to e-Voting will be sent out by email to ESPT members for the election of the ESPT Executive Board members.
Exposure of ESPT was accomplished at the Pharmacogenomics Research Network (PGRN) at the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in San Diego in March, and at the European Pharmacogenomics Implementation Consortium (Eu-PIC) Pharmacogenomics day, organized in Rotterdam meeting on May 26-27.
In the past 4 months, the ESPT board has worked hard to ensure that also in 2016 an interesting program for ESPT members is available! Please have a look at the 3rd ESPT Summerschool “State of the Art, Novel Concepts and Clinical Applications of Pharmacogenomics and Personalised Therapy”, to be held in Belgrade on August 20-25 and organized in collaboration with Dr Sanja Stankovic. Registration is now open.
On October 3-5, there will be the Santorini Conference, organized by Biologie Prospective, in collaboration with ESPT. The program of the Santorini Congress, with 24 expert speakers, will be a tribute to the work of Prof Gerard Siest. Oral presentation deadline is June 30, poster presentation deadline July 20. Do not miss this unique, bi-annual event, and sign up to participate!
Ron van Schaik